Novartis AG
https://www.novartis.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Novartis AG
China Approves Record New Cancer, Orphan Drugs In 2020 But Access Challenges Remain
Throughout 2020, China’s drive to introduce more and newer drugs to the market did not slow but was rather accelerated by the COVID-19 pandemic. But can people afford them?
Lung Cancer Failure Isn't The End For Merck KGaA And GSK's Bintrafusp
Key cancer asset is still looking for a Phase III validation after failing to outperform Keytruda in challenging frontline NSCLC setting.
Japan Regulators Kept On Track Despite Pandemic
While it was not as affected as some other countries, Japan still had the pandemic to deal with and regulators responded while managing to keep up regular product review work, including several world-first approvals. Coronavirus vaccine roll-outs and the first general annual reimbursement price cut are on the cards for this year.
Two-Tier Specialty Drug Policy: Part D Plans Gain Formulary Flexibility But Impact May Be Limited
Use of preferred and non-preferred specialty formulary tiers will be allowed but preferred tiers are not necessarily limited to generics and biosimilars and coinsurance for non-preferred specialty drugs cannot exceed 33%.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Admune Therapeutics
- Amblyotech, Inc.
- Advanced Accelerator Applications SA (AAAP) (BioSynthema, Inc.)
- Aspen Japan K.K.
- Biocine
- CELLforCURE SASU
- Chiron Corporation
- CIBA-GEIGY
- Corthera Inc.
- CoStim Pharmaceuticals Inc.
- ESBATech AG
- Fougera Pharmaceuticals, Inc.
- Hexal AG
- Lek Pharmaceuticals, Inc.
- Matrix Pharmaceuticals
- NeuTec Pharma
- Novartis Groupe France S.A.
- Novartis Pharmaceuticals
- Novartis Oncology
- Novogyne Pharmaceuticals (joint venture between Noven and Novartis)
- PowerVision, Inc.
- Protez Pharmaceuticals
- Sandoz Pharmaceuticals (Ever Neuro Pharma GmbH
- Ebewe Pharma)
- Selexys Pharmaceuticals Corporation
- Speedel Holding
- Spinifex Pharmaceuticals Pty. Ltd.
- Transcend Medical, Inc.
- Encore Vision, Inc.
- Ziarco Group Limited
- AveXis, Inc.
- BioLife Cell Bank, Inc.
- Endocyte, Inc.
- IFM Tre
- Zyma SA
- Annovation Biopharma, Inc.
- Boxford Subsidiary
- Curacyte Discovery GmbH
- Incline Therapeutics, Inc.
- ProFibrix B.V.
- Rempex Pharmaceuticals, Inc.
- Targanta Therapeutics Corporation
- Tenaxis Medical
- The Medicines Company
- Novartis Gene Therapies